mRNA |
temsirolimus |
FIMM |
pan-cancer |
AAC |
-0.44 |
0.006 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.006 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.007 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.009 |
mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |